Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Case report

Clinical manifestation and genetic findings in three boys with low molecular Weight Proteinuria - three case reports for exploring Dent Disease and Fanconi syndrome

Authors: Nan Duan, Chenwei Huang, Lu Pang, Shiju Jiang, Wenshuang Yang, Haixia Li

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Dent disease is an X-linked form of progressive renal disease. This rare disorder was characterized by hypercalciuria, low molecular weight (LMW) proteinuria and proximal tubular dysfunction, caused by pathogenic variants in CLCN5 (Dent disease 1) or OCRL (Dent disease 2) genes. Fanconi syndrome is a consequence of decreased water and solute resorption in the proximal tubule of the kidney. Fanconi syndrome caused by proximal tubular dysfunction such as Dent disease might occur in early stage of the disease.

Case presentation

Three cases reported in this study were 3-, 10- and 14-year-old boys, and proteinuria was the first impression in all the cases. All the boys presented with LMW proteinuria and elevated urine albumin-to-creatinine ratio (ACR). Case 1 revealed a pathogenic variant in exon 11 of CLCN5 gene [NM_001127899; c.1444delG] and a nonsense mutation at nucleotide 1509 [p.L503*], and he was diagnosed as Dent disease 1. Case 2 carried a deletion of exon 3 and 4 of OCRL1 gene [NM_000276.4; c.120-238delGA] and a nonsense mutation at nucleotide 171 in exon 5 [p.E57*], and this boy was diagnosed as Dent disease 2. Genetic analysis of Case 3 showed a missense mutation located in exon 2 of HNF4A gene [EF591040.1; c.253C > T; p.R85W] which is responsible for Fanconi syndrome. All of three pathogenic variants were not registered in GenBank.

Conclusions

Urine protein electrophoresis should be performed for patients with proteinuria. When patients have LMW proteinuria and/or hypercalciuria, definite diagnosis and identification of Dent disease and Fanconi syndrome requires further genetic analyses.
Literature
1.
go back to reference Mansour-Hendili L, Blanchard A, Le Pottier N, Roncelin I, Lourdel S, Treard C, Gonzalez W, Vergara-Jaque A, Morin G, Colin E, et al. Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1. Hum Mutat. 2015;36(8):743–52.PubMedCrossRef Mansour-Hendili L, Blanchard A, Le Pottier N, Roncelin I, Lourdel S, Treard C, Gonzalez W, Vergara-Jaque A, Morin G, Colin E, et al. Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1. Hum Mutat. 2015;36(8):743–52.PubMedCrossRef
2.
go back to reference Szczepanska M, Zaniew M, Recker F, Mizerska-Wasiak M, Zaluska-Lesniewska I, Kilis-Pstrusinska K, Adamczyk P, Zawadzki J, Pawlaczyk K, Ludwig M, et al. Dent disease in children: diagnostic and therapeutic considerations. Clin Nephrol. 2015;84(4):222–30.PubMedCrossRef Szczepanska M, Zaniew M, Recker F, Mizerska-Wasiak M, Zaluska-Lesniewska I, Kilis-Pstrusinska K, Adamczyk P, Zawadzki J, Pawlaczyk K, Ludwig M, et al. Dent disease in children: diagnostic and therapeutic considerations. Clin Nephrol. 2015;84(4):222–30.PubMedCrossRef
3.
go back to reference Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature. 2005;436(7049):424–7.PubMedCrossRef Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature. 2005;436(7049):424–7.PubMedCrossRef
4.
go back to reference Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, et al. Dent Disease with mutations in OCRL1. American journal of human genetics. 2005;76(2):260–7.PubMedCrossRef Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, et al. Dent Disease with mutations in OCRL1. American journal of human genetics. 2005;76(2):260–7.PubMedCrossRef
5.
go back to reference Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V. Dent’s disease: clinical features and molecular basis. Pediatr Nephrol. 2011;26(5):693–704.PubMedCrossRef Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V. Dent’s disease: clinical features and molecular basis. Pediatr Nephrol. 2011;26(5):693–704.PubMedCrossRef
6.
go back to reference Wu F, Reed AA, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, et al. Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent’s disease. Nephron Physiology. 2009;112(4):p53–62.PubMedCrossRef Wu F, Reed AA, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, et al. Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent’s disease. Nephron Physiology. 2009;112(4):p53–62.PubMedCrossRef
8.
go back to reference Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D. Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2015;30(9):1456–60.CrossRef Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D. Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2015;30(9):1456–60.CrossRef
9.
go back to reference Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskel Neuronal Interact. 2017;17(4):303–6. Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskel Neuronal Interact. 2017;17(4):303–6.
10.
go back to reference Maher OM, Moonat HR. Fanconi Anemia and Fanconi Syndrome: Time to Correct the Misnomers. J Pediatr Hematol Oncol. 2016;38(7):585.PubMedCrossRef Maher OM, Moonat HR. Fanconi Anemia and Fanconi Syndrome: Time to Correct the Misnomers. J Pediatr Hematol Oncol. 2016;38(7):585.PubMedCrossRef
11.
go back to reference Liu J, Shen Q, Li G, Xu H. HNF4A-related Fanconi syndrome in a Chinese patient: a case report and review of the literature. Journal of medical case reports. 2018;12(1):203.PubMedPubMedCentralCrossRef Liu J, Shen Q, Li G, Xu H. HNF4A-related Fanconi syndrome in a Chinese patient: a case report and review of the literature. Journal of medical case reports. 2018;12(1):203.PubMedPubMedCentralCrossRef
12.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine: official journal of the American College of Medical Genetics. 2015;17(5):405–24.CrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine: official journal of the American College of Medical Genetics. 2015;17(5):405–24.CrossRef
14.
go back to reference Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype. J Med Genet. 2014;51(3):165–9.PubMedCrossRef Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype. J Med Genet. 2014;51(3):165–9.PubMedCrossRef
15.
go back to reference van Berkel Y, Ludwig M, van Wijk JAE, Bokenkamp A. Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol. 2017;32(10):1851–9.PubMedCrossRef van Berkel Y, Ludwig M, van Wijk JAE, Bokenkamp A. Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol. 2017;32(10):1851–9.PubMedCrossRef
16.
go back to reference Ehlayel AM, Copelovitch L. Update on Dent Disease. Pediatric clinics of North America. 2019;66(1):169–78.PubMedCrossRef Ehlayel AM, Copelovitch L. Update on Dent Disease. Pediatric clinics of North America. 2019;66(1):169–78.PubMedCrossRef
17.
go back to reference Zhang H, Wang F, Xiao H, Yao Y. The ratio of urinary alpha1-microglobulin to microalbumin can be used as a diagnostic criterion for tubuloproteinuria. Intractable rare diseases research. 2018;7(1):46–50.PubMedPubMedCentralCrossRef Zhang H, Wang F, Xiao H, Yao Y. The ratio of urinary alpha1-microglobulin to microalbumin can be used as a diagnostic criterion for tubuloproteinuria. Intractable rare diseases research. 2018;7(1):46–50.PubMedPubMedCentralCrossRef
19.
go back to reference Sekine T, Komoda F, Miura K, Takita J, Shimadzu M, Matsuyama T, Ashida A, Igarashi T. Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2014;29(2):376–84.CrossRef Sekine T, Komoda F, Miura K, Takita J, Shimadzu M, Matsuyama T, Ashida A, Igarashi T. Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2014;29(2):376–84.CrossRef
20.
go back to reference Poroca DR, Pelis RM, Chappe VM. ClC Channels and Transporters: Structure, Physiological Functions, and Implications in Human Chloride Channelopathies. Front Pharmacol. 2017;8:151.PubMedPubMedCentralCrossRef Poroca DR, Pelis RM, Chappe VM. ClC Channels and Transporters: Structure, Physiological Functions, and Implications in Human Chloride Channelopathies. Front Pharmacol. 2017;8:151.PubMedPubMedCentralCrossRef
21.
go back to reference Lourdel S, Grand T, Burgos J, Gonzalez W, Sepulveda FV, Teulon J. ClC-5 mutations associated with Dent’s disease: a major role of the dimer interface. Pflug Arch: Eur J Physiol. 2012;463(2):247–56.CrossRef Lourdel S, Grand T, Burgos J, Gonzalez W, Sepulveda FV, Teulon J. ClC-5 mutations associated with Dent’s disease: a major role of the dimer interface. Pflug Arch: Eur J Physiol. 2012;463(2):247–56.CrossRef
22.
23.
go back to reference Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, et al. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Dis Models Mech. 2016;9(7):759–67.CrossRef Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, et al. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Dis Models Mech. 2016;9(7):759–67.CrossRef
24.
go back to reference Barbetti F, D’Annunzio G. Genetic causes and treatment of neonatal diabetes and early childhood diabetes. Best practice research Clinical endocrinology metabolism. 2018;32(4):575–91.PubMedCrossRef Barbetti F, D’Annunzio G. Genetic causes and treatment of neonatal diabetes and early childhood diabetes. Best practice research Clinical endocrinology metabolism. 2018;32(4):575–91.PubMedCrossRef
25.
go back to reference Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat. 2013;34(5):669–85.PubMedCrossRef Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat. 2013;34(5):669–85.PubMedCrossRef
Metadata
Title
Clinical manifestation and genetic findings in three boys with low molecular Weight Proteinuria - three case reports for exploring Dent Disease and Fanconi syndrome
Authors
Nan Duan
Chenwei Huang
Lu Pang
Shiju Jiang
Wenshuang Yang
Haixia Li
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-020-02225-6

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.